Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
DiscoveryProbe Protease Inhibitor Library
2026-09-13
A scenario-driven guide to using DiscoveryProbe™ Protease Inhibitor Library (SKU L1035) for more interpretable cell viability, proliferation, and cytotoxicity studies. It covers assay design, DMSO control, concentration planning, data interpretation, storage, and practical vendor selection.
-
Letrozole Workflow for Aromatase Research
2026-09-12
Letrozole provides a practical bridge from aromatase enzyme assays to receptor-level and endocrine phenotyping. This guide shows how to design concentration screens, preserve assay integrity, interpret ERα and FSH-related readouts, and troubleshoot common formulation and timing problems.
-
EdU Imaging Kits (488): S-Phase Detection
2026-09-11
EdU Imaging Kits (488) use 5-ethynyl-2'-deoxyuridine and click chemistry to label newly synthesized DNA without DNA denaturation. The K1175 workflow supports quantitative cell proliferation analysis by fluorescence microscopy and flow cytometry while preserving morphology and antigen-accessible epitopes.
-
Anagliptin (SK-0403) Vascular Research Workflows
2026-09-11
Anagliptin (SK-0403) supports two complementary research paths: quantitative DPP-4 inhibition assays and mechanistic ex vivo vascular pharmacology. This workflow uses the latest rabbit-aorta evidence to separate incretin biology from direct smooth-muscle effects involving Kv channels and SERCA pump regulation.
-
DAF-2 Diacetate: Interpreting NO in Nodule Senescence
2026-09-10
DAF-2 diacetate enables sensitive nitric oxide imaging, but fluorescence requires careful biological interpretation. This guide connects probe chemistry with sulfur-dependent soybean nodule senescence and shows how to design stronger NO assays.
-
Dual-Action Kinase Inhibitors and p38α Dephosphorylation
2026-09-10
The referenced preprint shows that selected kinase inhibitors can do more than block p38α MAP kinase activity: they can also accelerate WIP1-mediated dephosphorylation of the kinase activation loop. Structural and biochemical results connect this effect to an inhibitor-stabilized activation-loop conformation that exposes phospho-threonine, suggesting a strategy for designing inhibitors that combine catalytic blockade with phosphatase-directed regulation.
-
DdmDE Clears Plasmids by Bidirectional DNA Extrusion
2026-09-09
Yang et al. describe how the DdmDE defense module combines DNA-guided target recognition, force-assisted duplex opening, bidirectional single-stranded DNA extrusion, and site-specific cleavage to eliminate plasmids. The study shifts the mechanistic view of prokaryotic Argonaute defense from static target binding to a dynamic, kinetically controlled process with separable recognition, unwinding, and nuclease functions.
-
CH 223191 for Causal AhR Signaling Studies
2026-09-09
CH 223191 enables receptor-level testing of TCDD responses, CYP1A1 induction, and microbiota–tryptophan–AhR biology. This workflow-focused guide shows how to use the compound as an AhR signaling pathway inhibitor while separating validated product properties from exploratory ulcerative colitis applications.
-
Bergenin Reprograms γδT17 Cells in Psoriasis
2026-09-08
A 2026 Phytomedicine study identifies a PPARγ–PROX1–fatty acid oxidation pathway through which bergenin suppresses pathogenic γδT17 cells and reduces psoriasiform inflammation. Its combination of adoptive-transfer experiments, Seahorse metabolic analysis, co-immunoprecipitation, and ChIP-qPCR provides a mechanistic framework for selective IL-17A regulation.
-
Selective Autophagy Tunes IRF3 Antiviral Signaling
2026-09-08
Wu and colleagues showed that CALCOCO2/NDP52-dependent selective autophagy limits IRF3 stability in a virus load-dependent manner, while PSMD14 preserves IRF3 by removing K27-linked ubiquitin chains at lysine 313. The study defines a regulatory balance between type I interferon activation and immune suppression and offers a useful framework for analyzing transcription-factor turnover during antiviral signaling.
-
Neonatal iWAT Chromatin and Beige Adipogenesis
2026-09-07
This study integrates RNA-seq, H3K27ac ChIP-seq, imaging, qRT-PCR, and metabolic assays to define epigenetically active chromatin in neonatal inguinal white adipose tissue. Its principal advance is the identification of GABPα as a candidate regulator of beige adipocyte differentiation, linking chromatin activation to the metabolic and developmental biology of neonatal beige fat.
-
Moxidectin in Ergosterol-Targeted Antifungal Research
2026-09-07
Moxidectin is a macrocyclic lactone anthelmintic with an emerging use as a polyene-sensitizing tool in Candida albicans research. This practical guide connects assay design, formulation control, veterinary antiparasitic context, and troubleshooting for mechanism-driven translational studies.
-
Oltipraz for Nrf2 and MASLD Assays
2026-09-05
Oltipraz provides a defined Nrf2-activating comparator for separating phase II enzyme induction from the broader autophagy and ferroptosis effects observed with Qushi Huoxue ointment. This workflow connects chemoprevention research with MASLD assays while emphasizing solvent control, pathway-specific readouts, and cautious interpretation.
-
UHRF1, 5-mC, and Autophagy in Senile Osteoporosis
2026-09-04
The reference study identifies a mechanistic connection between UHRF1-dependent DNA 5-methylcytosine maintenance, super-enhancer redistribution, and TGM2-regulated autophagic flux in senile osteoporosis. Its multi-omics and perturbation framework links epigenetic remodeling to impaired mesenchymal stem cell osteogenesis and supports the UHRF1–TGM2 axis as a candidate route for investigating age-related bone loss.
-
Lipidated Nanophotosensitizers Disable Tumor EVs
2026-09-04
The reference study developed a palmitic acid-displayed nanophotosensitizer that traces tumor extracellular vesicles while simultaneously generating reactive oxygen species inside tumor cells and tumor-derived vesicles. This dual spatial activity suppressed primary tumor growth and prometastatic communication in multiple mouse models, providing a strategy that targets both the tumor source and its extracellular signaling network.